Pictet Asset Management
PRME icon

Pictet Asset Management’s Prime Medicine PRME Stock Holding History

Pictet Asset Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7K Hold
12,107
– – ﹤0.01% 2130
2026
Q1 		$42.1K Buy
+12,107
New +$46.1K ﹤0.01% 2091

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management's PRME Position: Q2 2026 in Review

Pictet Asset Management held its Prime Medicine (PRME) position steady in Q2 2026 at 12,107 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Pictet Asset Management first reported a position in PRME in Q1 2026 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Pictet Asset Management held 12,107 shares of Prime Medicine worth $44.7K as of Q2 2026.
  • Pictet Asset Management left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2130 holding.
  • Pictet Asset Management first reported a position in Prime Medicine in Q1 2026 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.